In terms of the differences in translocations, for both non-metastatic and metastatic alveolar rhabdomyosarcoma patients, the translocation of PAX3-FOXO1 was suggested to result in shorter survival than PAX7-FOXO1 translocation [45,46,47]. The gene discussed is PAX3; the disease is alveolar rhabdomyosarcoma.